PCRX
Pacira Biosciences Inc
Price:  
24.84 
USD
Volume:  
1,032,975.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PCRX WACC - Weighted Average Cost of Capital

The WACC of Pacira Biosciences Inc (PCRX) is 6.7%.

The Cost of Equity of Pacira Biosciences Inc (PCRX) is 8.50%.
The Cost of Debt of Pacira Biosciences Inc (PCRX) is 5.50%.

Range Selected
Cost of equity 7.30% - 9.70% 8.50%
Tax rate 29.40% - 42.30% 35.85%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.7% - 7.7% 6.7%
WACC

PCRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.70%
Tax rate 29.40% 42.30%
Debt/Equity ratio 0.55 0.55
Cost of debt 4.00% 7.00%
After-tax WACC 5.7% 7.7%
Selected WACC 6.7%